EIF2AK3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.46959999619756E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.71106999999893E-05 |
Normal-vs-Stage2 |
1.522450E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.620500E-04 |
Stage1-vs-Stage2 |
5.662800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.580200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.689000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.18040000013964E-07 |
Normal-vs-AfricanAmerican |
1.889770E-01 |
Normal-vs-Asian |
3.54359999998888E-06 |
Caucasian-vs-AfricanAmerican |
1.205600E-01 |
Caucasian-vs-Asian |
7.919900E-02 |
AfricanAmerican-vs-Asian |
8.915800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.822400E-04 |
Normal-vs-Female |
1.5318999999625E-06 |
Male-vs-Female |
4.271400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.159000E-03 |
Normal-vs-Extreme_Weight |
5.80869999999845E-05 |
Normal-vs-Obese |
1.412180E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.865800E-01 |
Normal_Weight-vs-Obese |
5.132200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.713000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.123800E-03 |
Normal-vs-Age(41-60Yrs) |
3.357200E-04 |
Normal-vs-Age(61-80Yrs) |
3.67789999999868E-05 |
Normal-vs-Age(81-100Yrs) |
5.817300E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.722800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.631400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.943200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.462200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.884200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.811200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.814400E-01 |
Normal-vs-Grade 3 |
4.094400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.606200E-01 |
Grade 2-vs-Grade 4 |
6.814400E-01 |
Grade 3-vs-Grade 4 |
4.094400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.46800000050607E-07 |
Normal-vs-N1 |
8.61990000045054E-07 |
N0-vs-N1 |
5.483400E-01 |
|
|